Literature DB >> 2921816

Acute lymphoblastic leukemia following treatment with human growth hormone in a boy with possible preanemic Fanconi's anemia.

E Wada1, M Murata, S Watanabe.   

Abstract

The patient had a low birth weight and was born with appearance anomalies including microcephalus, microphthalmia, hypoplastic mandible, double chin due to cutaneous fold, micropenis. Ability to move and intelligence appeared to develop normally, but growth was markedly retarded. In June 1982, at the age of 2 yr 4 mo, the patient underwent tolerance tests whereby a deficiency of human growth hormone (GH) was proved by poor GH secretion response. GH was administered until April 1985 when acute lymphoblastic leukemia developed. The patient's younger brother, born in 1986, had similar birth anomalies and was diagnosed as having Fanconi's anemia. It therefore seems possible that our patient developed his acute leukemia through the stimulatory effect which GH had on a predisposition to leukemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2921816

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  Malignant thymoma in a patient with growth hormone deficiency during growth hormone therapy.

Authors:  T Hasegawa; Y Hasegawa; S Koto; T Aso; Y Tsuchiya; A Hayashi; H Ishida; Y Morikawa
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

Review 2.  Safety of Pediatric rhGH Therapy: An Overview and the Need for Long-Term Surveillance.

Authors:  Stefano Cianfarani
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-24       Impact factor: 5.555

Review 3.  The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.

Authors:  Farhad Dehkhoda; Christine M M Lee; Johan Medina; Andrew J Brooks
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-13       Impact factor: 5.555

4.  Risk factors for leukemia occurrence among growth hormone users.

Authors:  S Watanabe; N Yamaguchi; Y Tsunematsu; A Komiyama
Journal:  Jpn J Cancer Res       Date:  1989-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.